PCSK9 Forum
March 2015
Facebook Twitter RSS YouTube
For latest updates
Register today
Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact

News from ACC Scientific Sessions 2015

What do the OSLER and ODYSSEY studies really show?

According to PCSK9 Forum Editor Professor Derick Raal, University of Witwatersrand, Johannesburg, South Africa two urgent questions remain.

Does this substantial LDL cholesterol lowering with PCSK9 monoclonal antibody therapy translate to reduction in cardiovascular outcomes in high cardiovascular risk patients? And are the PCSK9 inhibitors safe?


Read the report here »

CASCADE FH: Unmet needs in education about familial hypercholesterolaemia

Education, education, education......

Only about 50% of patients understood the risks of their condition.

Treatment was also suboptimal in nearly one-half of patients in the registry. 

Read the report here »

PCSK9 Education and Research Forum

Invotation from John Chapman
Aims & Objectives video
Read our Mission Statement
Partnership and outreach
Meet our Editorial Board
View Forthcoming Meetings
Send an invitation to join PCSK9 Forum to your colleagues
Latest Video

Familial hypercholesterolaemia: putting the patient first
Katherine Wilemon

View our YouTube channel »
  Supported by educational grants from: Amgen Lilly pFizer Sanofi  
Copyright PCSK9 Forum 2015. Please click here to unsubscribe from future mailings.